Grant: Engage Grants Program
Université de Montréal
$24,940.00
Proof of concept for a new drug delivery system, Polar Bones, in dogs
FY 2013-14
Summary
The administration of oral medication to an animal can be a challenge for many pet owners. As a consequence,the treatment protocol prescribed by the veterinarian might not be fully respected and this could alter theoutcome of the therapy, as well as to be associated with deleterious consequences: bacterial resistance, sideeffects associated with abrupt discontinuation of some drugs, creation of doubt about drug's effectiveness,about the veterinarian's competence, etc. Polar Bones is a frozen treat developed by the company KoolPets Inc.,intended to be used for long-term oral therapy in dogs. To this day, there is no available data to ensure thestability and the bioavailability of therapeutic agents that have been frozen such as a Polar Bone treat, and datapertaining to convenience of administration, palatability and general tolerance are scattered and only based onanecdotic facts. As analgesic treatments (primarily non-steroidal anti-inflammatory drugs; NSAIDs) have greatchances to be administered long-term in dogs, we propose to investigate the stability and the pharmacokineticsof meloxicam, the most prescribed NSAID in Canada for pet animals. Palatability, convenience ofadministration and general tolerance will be followed throughout the study as well. A two phases project isproposed: i) testing the stability of meloxicam incorporated to the Polar Bone frozen treat during an in vitrostudy; ii) testing the bioavailability of meloxicam following oral administration to laboratory dogs. Thewillingness of an animal to consume spontaneously a medicinal product would be beneficial in order tofacilitate successful administration of a treatment, and this is our hypothesis that a Polar Bone frozen treatcould be a solution to improve compliance to treatment.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
451460-2013
Name nom
Troncy, Eric
Department département
Biomédecine vétérinaire
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
24940
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
Proof of concept for a new drug delivery system, Polar Bones, in dogs
Keyword
NSERC
Application summary
The administration of oral medication to an animal can be a challenge for many pet owners. As a consequence,the treatment protocol prescribed by the veterinarian might not be fully respected and this could alter theoutcome of the therapy, as well as to be associated with deleterious consequences: bacterial resistance, sideeffects associated with abrupt discontinuation of some drugs, creation of doubt about drug's effectiveness,about the veterinarian's competence, etc. Polar Bones is a frozen treat developed by the company KoolPets Inc.,intended to be used for long-term oral therapy in dogs. To this day, there is no available data to ensure thestability and the bioavailability of therapeutic agents that have been frozen such as a Polar Bone treat, and datapertaining to convenience of administration, palatability and general tolerance are scattered and only based onanecdotic facts. As analgesic treatments (primarily non-steroidal anti-inflammatory drugs; NSAIDs) have greatchances to be administered long-term in dogs, we propose to investigate the stability and the pharmacokineticsof meloxicam, the most prescribed NSAID in Canada for pet animals. Palatability, convenience ofadministration and general tolerance will be followed throughout the study as well. A two phases project isproposed: i) testing the stability of meloxicam incorporated to the Polar Bone frozen treat during an in vitrostudy; ii) testing the bioavailability of meloxicam following oral administration to laboratory dogs. Thewillingness of an animal to consume spontaneously a medicinal product would be beneficial in order tofacilitate successful administration of a treatment, and this is our hypothesis that a Polar Bone frozen treatcould be a solution to improve compliance to treatment.